购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Aurora Kinase
    (3)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • Influenza Virus
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (3)
  • 5日内发货
    (1)
  • 35日内发货
    (2)
  • 6-8周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "aurora b (human)"的结果
筛选
搜索结果
TargetMol产品目录中 "

aurora b (human)

"的结果
  • 抑制剂&激动剂
    7
    TargetMol | Inhibitors_Agonists
  • 检测抗体
    1
    TargetMol | Antibody_Products
  • Hesperadin
    T6532422513-13-1
    Hesperadin 是 Aurora A 和 B 的 ATP 竞争性吲哚酮抑制剂,抑制 Aurora B 的 IC50值为250nM。它通过阻断核分裂和胞质分裂而抑制布鲁氏锥虫的生长。它也是一种广谱流感抗病毒剂。
    • ¥ 292
    In stock
    规格
    数量
  • PLX-4720
    PLX4720
    T2473918505-84-7
    PLX-4720 是一种有效且选择性的 B-Raf (V600E) 抑制剂,旨在阻断致癌B-Raf的ATP结合位点,IC50为 13 nM。
    • ¥ 465
    In stock
    规格
    数量
  • AZD 1152 (hydrochloride)
    T36199722543-50-2
    AZD 1152 is an orally bioavailable prodrug of AZD 1152-HQPA, a selective inhibitor of Aurora kinase B (IC50= 0.36 nM).1AZD 1152 is converted to AZD 1152-HQPA in plasma. Inhibition of Aurora B results in disruption of spindle checkpoint functions and chromosome alignment, resulting in inhibition of cytokinesis followed by apoptosis.2,3AZD 1152 inhibits tumor xenograft growthin vivo.4,5 1.Mortlock, A.A., Foote, K.M., Heron, N.M., et al.Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinaseJ. Med. Chem.50(9)2213-2224(2007) 2.Popescu, R., Heiss, E.H., Ferk, F., et al.Ikarugamycin induces DNA damage, intracellular calcium increase, p38 MAP kinase activation and apoptosis in HL-60 human promyelocytic leukemia cellsMutation Research709-71060-66(2011) 3.Moore, A.S., Blagg, J., Linardopoulos, S., et al.Aurora kinase inhibitors: Novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemiasLeukemia24(4)671-678(2010) 4.Wilkinson, R.W., Odedra, R., Heaton, S.P., et al.AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosisClin. Cancer. Res13(12)3682-3688(2007) 5.Yang, J., Ikezoe, T., Nishioka, C., et al.AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivoBlood110(6)2034-2040(2007)
    • 待估
    35日内发货
    规格
    数量
  • Binucleine 2
    T36801220088-42-6
    Binucleine 2 is an isoform-specific and ATP-competitive inhibitor of Drosophila Aurora B kinase (Ki = 0.36 μM), a kinase involved in cell division. It is specific for Drosophila Aurora B kinase, inhibiting it in a dose-dependent manner, with minimal inhibition of human or X. laevis Aurora B kinases at concentrations up to 100 μM. Binucleine 2 induces mitotic and cytokinesis defects in Drosophila Kc167 cells. It prevents Drosophila S2 cells from assembling a contractile ring during cell division when used at a concentration of 40 μM but does not affect ring ingression, suggesting that Aurora B kinase activity is not required for that step.
    • ¥ 630
    35日内发货
    规格
    数量
  • BI-847325
    T67851207293-36-4
    BI847325是MEK 和极光激酶 (AK)的一种选择性双重抑制剂, 对人类MEK2和AK-C 的IC50值分别为4和15 nM。
    • ¥ 289
    In stock
    规格
    数量
  • BPR1K653
    T712791192754-07-6
    BPR1K653 is a potent Aurora kinase inhibitor with potential anticancder activity. BPR1K653 specifically inhibited the activity of Aurora-A and Aurora-B kinase at low nano-molar concentrations in vitro. BPR1K653 was potent in targeting a variety of cancer cell lines regardless of the tissue origin, p53 status, or expression of MDR1. At the cellular level, BPR1K653 induced endo-replication and subsequent apoptosis in both MDR1-negative and MDR1-positive cancer cells. Importantly, it showed potent activity against the growth of xenograft tumors of the human cervical carcinoma KB and KB-derived MDR1-positive KB-VIN10 cells in nude mice. Finally, BPR1K653 also exhibited favorable pharmacokinetic properties in rats., BPR1K653 is a promising anti-cancer compound that has potential for the management of various malignancies, particularly for patients with MDR1-related drug resistance after prolonged chemotherapeutic treatments.
    • ¥ 10600
    6-8周
    规格
    数量
  • TY-011
    T898331389439-77-3
    TY-011是一种激活DNA损伤和细胞凋亡(Apoptosis)的Aurora A B激酶抑制剂。通过诱导不正常的微管-着丝粒附着,TY-011能有效抑制人胃癌细胞增殖,其对人胃癌细胞系的IC50值范围为0.11-4.49 μM。该化合物主要用于胃癌领域的科学研究。
    • 待询
    10-14周
    规格
    数量